Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Internal medicine, Rheumatoid arthritis, Immunology, Psoriatic arthritis, and Quality of life (healthcare).
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients*
Pneumomediastinum in non-intensive care unit hospitalized patients with COVID-19 pneumonia
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting
Phase angle could be a marker of microvascular damage in systemic sclerosis
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
Fatigue in systemic sclerosis: a systematic review.
PubMed 2019cited by 40position: last
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis”
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis.
PubMed 2019cited by 12position: first
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.
PubMed 2019cited by 9position: middle
Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis
Cannabinoids in Autoimmune and Rheumatic Diseases
AB1289 TESTING DIFFERENT ITEMS INCLUDED IN THE DEFINITION OF REMISSION IN A MULTICENTRE SLE COHORT
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome
OP0090 THE OCCURRENCE OF SUBCLINICAL AND CLINICAL ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS, RESULTS FROM THE 3-YEAR, MULTICENTER, PROSPECTIVE, OBSERVATIONAL, GIRRCS STUDY
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study
Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results
Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study